Status
Conditions
Treatments
About
During this project, the investigators want to explore in vitro changes in basal cells and the crosstalk with residing immune cells as potential pathogenic mechanisms in CRSwNP vs healthy controls by using surgically resected patient samples.
Full description
The investigators want to use patient and healthy control samples to study/compare the following aspects in vitro:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
300 participants in 3 patient groups
Loading...
Central trial contact
Peter Hellings, MD, PhD; Dominique Bullens, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal